Clinical trial
A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant Papua New Guinean Women
NCT02575755 is registered in ClinicalTrials.gov with Papua New Guinea Institute of Medical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant Papua New Guinean Women
- Lead sponsor
- Papua New Guinea Institute of Medical Research
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2012
- Completion date
- October 31, 2016
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinical efficacy, drug kinetics, infections, plasmodia, pregnancy